BioZ Coverage Expansion Effort Requires Another Study, Firm Says
This article was originally published in The Gray Sheet
Executive Summary
CardioDynamics will develop an additional trial of its BioZ impedance cardiography (ICG) test for managing drug-resistant hypertension patients following CMS' proposed rejection of expanded Medicare coverage for the procedure